The 13 most recent market catalysts affecting $AMIX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 55
Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye
Autonomix Medical's announcement of a new European patent for 'Systems for Assessing Neural Activity in an Eye' is a positive development for the company. This patent expands their…
Aug 25, 2026
Corporate Catalyst
Bullish
Impact 85
Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why
Autonomix Medical (AMIX) announced a warrant inducement agreement where an investor will immediately exercise existing warrants, providing the company with approximately $4.9 milli…
Aug 24, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Monday's After-Market Session
This filing highlights the volatility in the healthcare sector during after-market trading, with several small-cap companies experiencing significant price swings. Autonomix Medica…
Aug 24, 2026
Corporate Catalyst
Bullish
Impact 75
Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.”
This headline represents a significant corporate catalyst for Autonomix Medical. The granting of a patent, especially one with such broad implications for regulating organ and tumo…
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 65
Autonomix Medical shares are trading lower. The company announced the completion of its GLP pre-clinical study.
The completion of a pre-clinical study is a standard milestone in biotechnology, but the negative market reaction for Autonomix Medical (AMIX) indicates that the news either fell s…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 75
Autonomix Medical Announces Completion Of GLP Pre-Clinical Study In Porcine Models; Says Final Histopathology, Laboratory Findings Support Safety And Performance Objectives Ahead Of FDA Submission
The completion of GLP pre-clinical studies with positive safety and performance findings is a critical milestone for Autonomix Medical. It significantly de-risks their product deve…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 95
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
Autonomix Medical Inc. (AMIX) has secured U.S. Patent No. 12,433,670, which protects its innovative technology for treating multiple cancers (pancreatic, prostate, breast, colorect…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Autonomix Medical shares are trading higher after the company announced the issuance of U.S. Patent No. 12,433,670, titled "Systems and Methods for Treating Cancer and/or Augmenting Organ Function."
The issuance of a U.S. patent, especially one with broad claims like 'Treating Cancer and/or Augmenting Organ Function,' is a significant corporate catalyst for a biotechnology com…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 75
Autonomix Medical Shares Halted On Circuit Breaker To The Upside, Stock Now Up 116.73%
The headline signals a major positive development for Autonomix Medical, likely a clinical trial success, regulatory approval, or a significant partnership, leading to a dramatic i…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 75
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why
Autonomix Medical (AMIX) saw a substantial after-hours rally following two key disclosures. First, the company filed an 8-K registering 857,462 shares for resale from Series D warr…
Jul 15, 2026
Corporate Catalyst
Bullish
Impact 65
Autonomix Medical Granted U.S. Patent For Overactive Bladder Diagnosis And Treatment Platform
The patent grant is a positive development for Autonomix Medical, solidifying its intellectual property and potentially enhancing its valuation. While not an immediate revenue driv…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 55
Autonomix Medical Receives Canadian Patent For 'Endoscopic Sympathectomy Systems And Methods'
Autonomix Medical has secured a Canadian patent for its innovative endoscopic sympathectomy systems, adding to its existing patents in the US and Europe. This development is signif…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.